Evidence map›Paper›PMID 38779538›Full record

ArticleNAR molecular medicine2024

Frequencies and spectra of aflatoxin B

Irina G Minko, Michael M Luzadder, Vladimir L Vartanian, Sean P M Rice, Megan M Nguyen, Monica Sanchez-Contreras, Phu Van, Scott R Kennedy, Amanda K McCullough, R Stephen Lloyd

Abstract read
In one paragraph

Article in NAR molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Aflatoxin BEnvironmental and molecular mutagenesis · 2025
    Article
  6. Aflatoxin BEnvironmental toxicology and pharmacology · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Irina G MinkoOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0002-0012-2265
Michael M LuzadderOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-7227-6207
Vladimir L VartanianOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.
Sean P M RiceOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-7712-4667
Megan M NguyenDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Monica Sanchez-ContrerasDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Phu VanTwinStrand Biosciences, Inc., Seattle, WA, USA.
Scott R KennedyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-4444-1145
Amanda K McCulloughOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.
R Stephen LloydOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas -Administrative SupplementR01ES031086 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LLOYD, R. STEPHEN · 2020 to 2024
$2.0M
Massively Parallel Single Cell Detection of Rare Variants with Split-Pool Combinatorial IndexingR21HG011229 · NHGRI · UNIVERSITY OF WASHINGTON · PI KENNEDY, SCOTT ROBERT, SEELIG, GEORG · 2020 to 2020
$622k
Exploiting Urine Derived DNA for the Assessment of Bladder Cancer using High Accuracy SequencingR21CA259780 · NCI · UNIVERSITY OF WASHINGTON · PI KENNEDY, SCOTT ROBERT · 2021 to 2022
$395k
NCI NIH HHS P30 CA069533NCI NIH HHS R21 CA259780NHGRI NIH HHS R21 HG011229NIEHS NIH HHS R01 ES031086
6 · The paper itself

Abstract

Increased risk for the development of hepatocellular carcinoma (HCC) is driven by a number of etiological factors including hepatitis viral infection and dietary exposures to foods contaminated with aflatoxin-producing molds. Intracellular metabolic activation of aflatoxin B

Identifiers

PMID38779538
PMCPMC11105970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.